Form 4: National Healthcare Corp COO Exercises Stock Options, Increases Beneficial Ownership
Insider Transaction Report
National Healthcare Corp's President and COO, Robert Michael Ussery, reported the exercise of stock options and a subsequent increase in his beneficial ownership of company common stock.
Summary
- Robert Michael Ussery, President and COO of National Healthcare Corp (NHC), reported changes in his beneficial ownership of NHC common stock.
- On June 26, 2025, Ussery acquired 4,234 shares of common stock at an exercise price of $63.96 per share through the exercise of stock options.
- These options were granted on February 18, 2022, under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- Concurrently, 2,007 shares were disposed of at a price of $109.05 per share to cover the exercise price and withholding tax obligations.
- Following these transactions, Ussery's direct beneficial ownership of NHC common stock stands at 157,948 shares.
- Ussery retains additional unexercised options to purchase common stock, including 9,000 shares at an exercise price of $53.94, 13,500 shares at $94.10, and 15,000 shares at $90.62.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as a key executive exercised options, indicating confidence, despite a portion of shares being sold to cover taxes and exercise costs. It's largely a routine compensation event.
Positives
- The exercise of stock options by a key executive like the President and COO generally signals confidence in the company's long-term prospects and valuation.
- The transaction resulted in a net increase of 2,227 shares (4,234 acquired minus 2,007 disposed) in the executive's direct beneficial ownership.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled and routine compensation event rather than a reaction to immediate market conditions.
Negatives
- A significant portion of the shares acquired (2,007 out of 4,234, or approximately 47.4%) were immediately sold to cover the exercise price and tax obligations, reducing the net increase in the executive's direct equity stake.
Future Outlook
This Form 4 filing does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This filing is a routine insider transaction report common across all publicly traded companies, reflecting executive compensation and equity ownership changes. It does not provide specific insights into broader healthcare industry trends or competitive dynamics.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Reference | The exercised stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan, indicating the company's framework for executive equity compensation. | 02/18/2022 | Reinforces the company's established executive compensation structure and adherence to regulatory exemptions (Rule 16b-3(d)). |
Stakeholder Impact
- Shareholders: Provides transparency into executive equity ownership and compensation, potentially signaling management's confidence in the company's stock performance.
Next Steps
- Future potential exercises of remaining stock options held by the executive on their respective exercisable dates.
Key Dates
| Date | Description |
|---|---|
| 02/18/2022 | Grant date of the stock options that were exercised. |
| 02/18/2023 | Date the exercised stock options became exercisable. |
| 03/08/2024 | Date 9,000 stock options became exercisable. |
| 03/05/2025 | Date 13,500 stock options became exercisable. |
| 06/26/2025 | Date of the stock option exercise and share disposition. |
| 02/24/2026 | Date 15,000 stock options became exercisable. |
| 02/18/2027 | Expiration date of the exercised stock options. |
| 03/08/2028 | Expiration date of 9,000 stock options. |
| 03/05/2029 | Expiration date of 13,500 stock options. |
| 02/24/2030 | Expiration date of 15,000 stock options. |
Keywords
National Healthcare Corp, NHC, Insider Transaction, Form 4, Stock Options, Beneficial Ownership, Executive Compensation, Rule 10b5-1, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.